About Contact Us Careers
Sign In

Heart Attack Diagnostics Market Size & Share, by Type (Non-Invasive, Minimally Invasive); Test (Electrocardiography, Blood Tests, Computerized Cardiac Tomography, Echocardiography, Coronary Angiography); End-user (Hospitals & Clinics, Diagnostic Center, Ambulatory & Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4446
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Companies Dominating the Heart Attack Diagnostics Market

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ACS Diagnostics, Company
    • Asahi Kasei Corporation
    • AstraZeneca PLC
    • Beckman Coulter, Inc.
    • Hill-Rom Services, Inc
    • Koninklijke Philips N.V.
    • General Electric Company
    • Toshiba Corporation
    • Schiller Americas, inc.  
Browse Key Market Insights with Data Illustration:

In the News

  • General Electric Company, a global leader in medical technology, diagnostics and digital solutions, has launched the first AI-enabled Cath lab made in India - Optima IGS 320, enabling cardiac care in India. The lab is located at the new factory of Wipro GE Healthcare in Bengaluru. The managing director of the company further suggested that AI has the requisite potential to enhance the care pathway.  

  • Abbott Laboratories to received CE marking for its first troponin test that may be able to allow prediction of heart attacks months in advance in apparently healthy adults. It can help the physicians to determine necessary medical steps to prevent heart diseases.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4446
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rise in geriatric population worldwide and prevalence of unhealthy lifestyles among people are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023-2033.

Higher price associated with diagnostic products is estimated to challenge the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, test, end user and, by region.

The hospitals & clinics segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying